These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6213717)

  • 1. Functional characteristics of a Ficoll-separated mouse bone marrow cell population involved in skin allograft prolongation.
    Gozzo JJ; Crowley M; Maki T; Monaco AP
    J Immunol; 1982 Oct; 129(4):1584-8. PubMed ID: 6213717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
    De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
    J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
    Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of suppressor cell mechanism in antilymphocyte serum-induced skin allograft tolerance in mice.
    Rieger M; Hilgert I; Kristofová H; Vlachov K
    Folia Biol (Praha); 1979; 25(4):220-30. PubMed ID: 159195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
    Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
    De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
    Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice.
    Smith JP; Kasten-Jolly J; Field LJ; Thomas JM
    Transplantation; 1994 Aug; 58(3):324-9. PubMed ID: 8053056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
    Wood ML; Monaco AP
    J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture.
    De Fazio SR; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice.
    De Fazio SR; Kowolenko M; Monaco AP; Gozzo JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):547-8. PubMed ID: 2856297
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
    de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
    Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of skin allograft survival in ATS-treated mice by post-transplant injections of species antigenic extracts.
    Chutná J; Sládecek M; Holán V; Hasek M
    Folia Biol (Praha); 1984; 30(2):109-22. PubMed ID: 6233181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.